期刊
JOURNAL OF CLINICAL PATHOLOGY
卷 64, 期 11, 页码 990-994出版社
BMJ PUBLISHING GROUP
DOI: 10.1136/jclinpath-2011-200099
关键词
-
类别
Background Cell-cell adhesion molecules such as desmosomes and cytokeratins may play a major role in epithelial-mesenchymal transition and have been suggested to have a relevant impact on tumour progression. This study investigated 15 biomarkers in pancreatic ductal adenocarcinoma (PDAC) and correlated the results with clinicopathological parameters. Methods Tissue microarrays of 115 R0-resected PDAC were constructed to evaluate the protein expression of 15 in genome-wide expression profiling differentially expressed biomarkers. Results At the protein level a high expression of desmocollin 2 (DSC2) was observed in 90.4%, DSC1 (67.6%), DSC3 (0.9%), MDM2 (16.2%), CEA (64.8%), CK7 (85.2%), CK8 (96.5%), CK18 (96.5%), CK19 (93.9%), CK20 (11.5%), CA19-9 (86.6%), TLE1 (8.7%), PITX1 (91.2%), factor H (95.7%) and mesothelin (9.6%). Reduced expression of DSC2 was statistically correlated with shorter patient survival, higher tumour grading and positive lymph node status (p=0.008, p=0.029, p=0.011, respectively). In multivariable analysis reduced expression of DSC2, higher tumour grading and positive lymph node status were independently correlated with shorter patient survival. Conclusions Reduced expression of DSC2 is independently correlated with shorter patient survival, higher tumour grading and positive lymph node status in PDAC and could serve as a prognostic marker.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据